ciprofloxacin and clavulanic acid

ciprofloxacin has been researched along with clavulanic acid in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.85)	18.7374
1990's	12 (23.08)	18.2507
2000's	20 (38.46)	29.6817
2010's	11 (21.15)	24.3611
2020's	7 (13.46)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D	1
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Beale, AS; Gisby, J; Wightman, BJ	1
Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J	1
DiPersio, JR; Ficorilli, SM; Kirk, M; Matsen, JM; Saxon, B; Spencer, HJ; Wright, DN	1
Abbas, AM; Chandra, V; Dongaonkar, PP; Goel, PK; Kacker, P; Patel, NA; Shrivastava, OP; Thakkar, B; Tillotson, GS	1
Bellaïche, G; Grando, V; Le Pennec, MP; Ley, G; Nouts, A; Paugam, B; Slama, JL	1
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ	1
Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA	1
Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA	1
Constantoulaki, S; Paniara, O; Platsouka, E; Zissis, NP	1
Caballero, MD; Cañizo, MC; Colino, CI; Galende, J; García-Sanz, R; Gil-Hurlé, A; Hernández, JM; San Miguel, JF; Vallejo, C; Vázquez, L	1
Chanock, S; Freifeld, A; Gill, V; Hicks, JE; Hiemenz, J; Hiemenz, S; Lewis, L; Marchigiani, D; Pizzo, PA; Steinberg, SM; Walsh, T	1
Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M	1
Keane, CT; McCarthy, ND; McConkey, SJ	1
Kanayama, A; Kobayashi, I; Mochida, O; Naito, S; Saika, T; Tanaka, M; Tunoe, H	1
Fernández, F; Martínez-Martínez, L; Perea, EJ	1
Gaillat, J	1
Aimoni, C; Amoroso, C; Vindigni, MR	1
Millán Rodríguez, F; Rousaud Barón, A; Rousaud Barón, F	1
Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R	1
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M	1
Böhringer, R; Krautmacher, C; Vetter, H; Weisser, B	1
Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA	1
Keam, SJ; Perry, CM	1
Shmelev, EI	1
Ashkenazi, S; Bishara, J; Lev, B; Levy, I; Livne, G; Ofir, O; Pitlik, S; Samra, Z	1
Aaron, L; Bachelier, MN; Guimard, Y; Heurtebise, F	1
Bikhazi, N; Carroll, S; Crenshaw, K; Dohar, J; Dupre, S; Giles, W; McLean, C; Moe, R; Reese, B; Roland, P; Stroman, D; Wall, M	1
Borrows, R; Cairns, T; Chusney, G; Griffith, M; Hakim, N; James, A; Loucaidou, M; McLean, A; Palmer, A; Papalois, V; Taube, D; Van Tromp, J	1
Antoun, S; Chachaty, E; Farhat, H; Nitenberg, G; Zahar, JR	1
Elis, A; Lishner, M; Manor, Y; Shacham-Abulafia, A	1
Adam, HJ; DeCorby, MR; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Simner, PJ; Walkty, A; Zhanel, GG	1
Buzała, K; Gospodarek, E; Pluta, J; Sekowska, A	1
Chan, ES; Hou, SM; Lo, KL; Ng, CF; Yip, SK	1
Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C	1
Celik, T; Kosker, M; Turkoglu, EB; Yuksel, D	1
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K	1
Azzi-Achkouty, S; Farhat, J; Hallit, S; Hleihel, W; Hobeika, E; Saab, J; Salameh, P; Sili, G	1
Aminu, RF; Mofolorunsho, KC; Ocheni, HO; Olowonibi, OO; Omatola, CA	1
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T	1
Hu, S; Lou, Z; Shen, Y; Tu, M	1
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z	1
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I	1
Chaleshtori, RS; Emami, MS; Rahimi, E; Shakerian, A	1

Reviews

4 review(s) available for ciprofloxacin and clavulanic acid

Article	Year
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis]. Presse medicale (Paris, France : 1983), 2001, Oct-27, Volume: 30, Issue:31 Pt 2 Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Maximal Expiratory Flow-Volume Curves; Multicenter Studies as Topic; Penicillins; Placebos; Practice Guidelines as Topic; Prognosis; Recurrence; Respiratory Function Tests; Tetracycline; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination	2001
[Actinomycosis]. Praxis, 2004, Feb-04, Volume: 93, Issue:6 Topics: Actinomycosis, Cervicofacial; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Clindamycin; Gentamicins; Humans; Male; Prognosis; Recurrence; Time Factors; Tomography, X-Ray Computed	2004
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease]. Problemy tuberkuleza i boleznei legkikh, 2004, Issue:12 Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors	2004
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China. The American journal of tropical medicine and hygiene, 2022, 10-12, Volume: 107, Issue:4 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms	2022

Trials

9 trial(s) available for ciprofloxacin and clavulanic acid

Article	Year
Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice. The Journal of antimicrobial chemotherapy, 1989, Volume: 24, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Urinary Tract Infections	1989
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. The New England journal of medicine, 1999, Jul-29, Volume: 341, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia	1999
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can The New England journal of medicine, 1999, Jul-29, Volume: 341, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxicillin; Antineoplastic Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Prospective Studies; Survival Rate	1999
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:9 Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clindamycin; Critical Pathways; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome	2004
Prulifloxacin. Drugs, 2004, Volume: 64, Issue:19 Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Dioxolanes; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Humans; Italy; Molecular Structure; New Zealand; Pefloxacin; Piperazines; Prodrugs; Quinolones; Urinary Tract Infections	2004
Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics, 2006, Volume: 118, Issue:3 Topics: Acute Disease; Administration, Oral; Administration, Topical; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media, Suppurative; Penicillins; Treatment Outcome	2006
The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation. Therapeutic drug monitoring, 2007, Volume: 29, Issue:1 Topics: Administration, Oral; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Enterohepatic Circulation; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Mycophenolic Acid; Prospective Studies; Time Factors	2007
Randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy. Chinese medical journal, 2012, Volume: 125, Issue:14 Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Clavulanic Acid; Humans; Male; Prostate; Rectum; Ultrasonography	2012
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-20, Volume: 31, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clavulanic Acid; Double-Blind Method; Drug Combinations; Female; Fever; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Quinolines; Risk Factors; Treatment Outcome	2013

Other Studies

39 other study(ies) available for ciprofloxacin and clavulanic acid

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid	2009
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae	1991
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8 Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Fleroxacin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination	1990
Evaluation of four newer antimicrobial agents in the Avantage susceptibility test system. Journal of clinical microbiology, 1989, Volume: 27, Issue:10 Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefotetan; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Evaluation Studies as Topic; Microbial Sensitivity Tests; Norfloxacin	1989
[Ulcerative hemorrhagic proctitis caused by Klebsiella oxytoca after treatment with an amoxicillin-clavulanic acid combination]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:5 Topics: Adult; Amoxicillin; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Colitis, Ulcerative; Drug Resistance, Microbial; Humans; Klebsiella; Klebsiella Infections; Male; Peptic Ulcer Hemorrhage; Proctocolitis	1994
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin	1996
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors	1996
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Gram-Negative Bacterial Infections; Humans; Mutation; Ticarcillin; Xanthomonas	1996
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:5 Topics: Amoxicillin; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam	1997
Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients. Hematology and cell therapy, 1997, Volume: 39, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Analysis of Variance; Bacterial Infections; Ciprofloxacin; Clavulanic Acid; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Neutropenia; Risk Factors; Treatment Outcome	1997
Primary peritonitis due to nonenteric salmonellae. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:1 Topics: Adolescent; Aged; Amoxicillin; Cefotaxime; Ciprofloxacin; Clavulanic Acid; Fatal Outcome; Humans; Male; Metronidazole; Peritonitis; Salmonella; Salmonella Infections; Salmonella typhimurium; Treatment Outcome	1999
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates. Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2 Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Gonorrhea; Humans; Levofloxacin; Naphthyridines; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin	2000
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2 Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline	1999
[A case of temporal arteritis presenting with sensorineural hearing loss]. Recenti progressi in medicina, 2001, Volume: 92, Issue:12 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Giant Cell Arteritis; Hearing Loss, Sensorineural; Humans; Male; Methylprednisolone; Penicillins	2001
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)]. Actas urologicas espanolas, 2003, Volume: 27, Issue:3 Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Female; Follow-Up Studies; Fosfomycin; Glycopeptides; Humans; Pilot Projects; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vaginosis, Bacterial	2003
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy]. Actas urologicas espanolas, 2003, Volume: 27, Issue:4 Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin	2003
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections	2004
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. The Israel Medical Association journal : IMAJ, 2005, Volume: 7, Issue:5 Topics: Adult; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Child; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Humans; In Vitro Techniques; Israel; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Penicillanic Acid; Piperacillin; Prevalence; Tazobactam	2005
[Pseudomembranous diphtheria caused by Corynebacterium ulcerans]. La Revue de medecine interne, 2006, Volume: 27, Issue:4 Topics: Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Corynebacterium; Diphtheria; Dogs; Drug Therapy, Combination; Exotoxins; Female; Humans; Pharyngitis; Time Factors; Treatment Outcome	2006
[Two cases of Bacillus infection and immunodepression]. Medecine et maladies infectieuses, 2008, Volume: 38, Issue:11 Topics: Amoxicillin; Anti-Bacterial Agents; Bacillus; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Middle Aged; Sepsis; Shock, Septic; Treatment Outcome	2008
[Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study]. Harefuah, 2010, Volume: 149, Issue:6 Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Clavulanic Acid; Humans; Infusions, Parenteral; Lymphoma, Non-Hodgkin; Neoplasm Staging; Neutropenia; Retrospective Studies	2010
Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2011
[Susceptibility of Klebsiella oxytoca to selected antibiotics]. Medycyna doswiadczalna i mikrobiologia, 2011, Volume: 63, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Humans; Klebsiella oxytoca; Microbial Sensitivity Tests; Minocycline; Tigecycline; Wounds and Injuries	2011
Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report. Seminars in ophthalmology, 2013, Volume: 28, Issue:2 Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Clavulanic Acid; Conjunctivitis, Bacterial; Dacryocystitis; DNA, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Francisella tularensis; Humans; Lymphatic Diseases; Pregnancy; Pregnancy Complications, Infectious; Submandibular Gland Diseases; Tularemia	2013
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. Advances in experimental medicine and biology, 2016, Volume: 952 Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome	2016
Are antibiotics substandard in Lebanon? Quantification of active pharmaceutical ingredients between brand and generics of selected antibiotics. BMC pharmacology & toxicology, 2020, 02-22, Volume: 21, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Drug Combinations; Drug Labeling; Drugs, Generic; Lebanon; Quality Control	2020
Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing African health sciences, 2021, Volume: 21, Issue:2 Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Clavulanic Acid; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Nigeria; Prevalence; Young Adult	2021
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique. International journal of antimicrobial agents, 2022, Volume: 60, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance. Current microbiology, 2022, Oct-15, Volume: 79, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2022
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates. Scientific reports, 2023, 01-09, Volume: 13, Issue:1 Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing	2023
Distribution of Virulence Genes in BioMed research international, 2023, Volume: 2023 Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Clavulanic Acid; Erythromycin; Gentamicins; Humans; Iran; Nalidixic Acid; Virulence	2023